E.E. Geduld’s AbbVie ABBV Stock Holding History

E.E. Geduld’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-11,400	Closed	-$620K	–	193
2015 Q3	$620K	Sell	11,400 -446	-4%	-$29K	0.58%	31
2015 Q2	$796K	Buy	+11,846	New	+$773K	0.5%	33
2014 Q2	–	Sell	-10,000	Closed	-$514K	–	303
2014 Q1	$514K	Hold	10,000	–	–	0.28%	97
2013 Q4	$528K	Buy	10,000 +5,000	+100%	+$246K	0.25%	82
2013 Q3	$224K	Hold	5,000	–	–	0.14%	164
2013 Q2	$207K	Buy	+5,000	New	+$219K	0.15%	153

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

E.E. Geduld's ABBV Position: Q4 2015 in Review

E.E. Geduld sold out of AbbVie (ABBV) in Q4 2015, closing a stake of 11,400 shares — an estimated $620K sold.

E.E. Geduld first reported a position in ABBV in Q2 2013 and held it in 6 quarters. The position peaked at $796K in Q2 2015. 1,637 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

E.E. Geduld reported no remaining AbbVie position as of Q4 2015 after selling out during the quarter.
E.E. Geduld sold 11,400 AbbVie shares in Q4 2015, an estimated $620K.
E.E. Geduld first reported a position in AbbVie in Q2 2013 and held it in 6 quarters.
E.E. Geduld's AbbVie position peaked at $796K in Q2 2015.
1,637 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on E.E. Geduld's 13F filing for Q4 2015, filed 2 Feb 2016.